| Reshma Kewalramani |
CEO & President, Director |
$48,839,252 |
-$15,843,087 |
-24% |
27 Feb 2026 |
| Amit Sachdev |
EVP Chief Patient & Ext Af Off |
$31,495,990 |
-$28,377,385 |
-47% |
24 Feb 2026 |
| Stuart A. Arbuckle |
Evp, Coo |
$28,594,582 |
|
|
01 Jul 2025 |
| BRUCE I. SACHS |
Director |
$24,446,598 |
+$1,948,416 |
+8.7% |
15 Jan 2026 |
| CHARLES F. WAGNER JR |
Evp, Co & Fo |
$22,820,544 |
-$12,427,252 |
-35% |
24 Feb 2026 |
| Ourania Tatsis |
EVP, Chief Reg. & Quality Off. |
$22,743,185 |
-$7,346,769 |
-24% |
24 Feb 2026 |
| Carmen Bozic |
EVP and CMO |
$18,124,017 |
-$1,118,642 |
-5.8% |
27 Feb 2026 |
| JEFFREY M. LEIDEN |
Executive Chairman, Director |
$17,073,496 |
-$60,942,657 |
-78% |
24 Feb 2026 |
| DAVID ALTSHULER |
EVP, Chief Scientific Officer |
$15,630,492 |
-$3,285,394 |
-17% |
22 Jan 2026 |
| Bastiano Sanna |
EVP, Cell & Genetic Therapies |
$13,426,165 |
|
|
05 May 2023 |
| Joy Liu |
EVP and Chief Legal Officer |
$11,313,343 |
-$442,396 |
-3.8% |
02 Mar 2026 |
| Edward Morrow Atkinson III |
EVP, Chief Technical Ops. Off. |
$8,964,403 |
-$3,598,635 |
-29% |
24 Feb 2026 |
| Duncan McKechnie |
EVP, Chief Commercial Officer |
$8,586,351 |
-$2,394,365 |
-22% |
24 Feb 2026 |
| Jonathan Biller |
EVP and Chief Legal Officer |
$6,643,054 |
-$4,076,426 |
-38% |
24 Feb 2026 |
| DIANA MCKENZIE |
Director |
$3,594,392 |
|
|
01 May 2025 |
| Alan M. Garber |
Director |
$3,583,758 |
|
|
01 May 2025 |
| Mark E. Bunnage |
EVP, Chief Scientific Officer |
$3,542,573 |
-$2,984,770 |
-46% |
24 Feb 2026 |
| Kristen Ambrose |
SVP & Chief Accounting Officer |
$3,201,776 |
-$1,978,864 |
-38% |
26 Feb 2026 |
| Terrence C. Kearney |
Director |
$2,995,241 |
|
|
01 May 2024 |
| LLOYD CARNEY |
Director |
$2,632,155 |
|
|
19 Nov 2025 |
| Suketu Upadhyay |
Director |
$2,345,736 |
|
|
15 Jan 2026 |
| Sangeeta N. Bhatia |
Director |
$2,149,500 |
-$438,204 |
-17% |
13 Feb 2026 |
| Nancy Thornberry |
Director |
$1,113,486 |
|
|
01 May 2025 |
| Jennifer Schneider |
Director |
$831,889 |
|
|
01 May 2025 |
| Yuchun Lee |
Director |
$283,841 |
|
|
01 May 2023 |
| MARGARET G. MCGLYNN |
Director |
$283,841 |
|
|
01 May 2023 |
| Michel Lagarde |
Director |
$256,199 |
|
|
01 May 2025 |